New York State Common Retirement Fund cut its stake in shares of PharMerica Co. (NYSE:PMC) by 36.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 31,000 shares of the company’s stock after selling 17,854 shares during the quarter. New York State Common Retirement Fund owned approximately 0.10% of PharMerica worth $908,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in PMC. Russell Investments Group Ltd. grew its stake in shares of PharMerica by 124.5% during the 2nd quarter. Russell Investments Group Ltd. now owns 4,886 shares of the company’s stock valued at $128,000 after acquiring an additional 2,710 shares during the period. Schwab Charles Investment Management Inc. boosted its stake in PharMerica by 8.0% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 265,654 shares of the company’s stock worth $6,974,000 after purchasing an additional 19,780 shares during the period. Arizona State Retirement System boosted its stake in PharMerica by 1.2% in the 2nd quarter. Arizona State Retirement System now owns 16,216 shares of the company’s stock worth $426,000 after purchasing an additional 200 shares during the period. SG Americas Securities LLC boosted its stake in PharMerica by 39.7% in the 2nd quarter. SG Americas Securities LLC now owns 7,206 shares of the company’s stock worth $189,000 after purchasing an additional 2,047 shares during the period. Finally, Legal & General Group Plc boosted its stake in PharMerica by 8.9% in the 2nd quarter. Legal & General Group Plc now owns 59,895 shares of the company’s stock worth $1,572,000 after purchasing an additional 4,892 shares during the period. Institutional investors own 89.97% of the company’s stock.
PMC has been the subject of several recent analyst reports. Zacks Investment Research downgraded PharMerica from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. ValuEngine downgraded PharMerica from a “buy” rating to a “hold” rating in a research note on Friday, September 22nd. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $30.50.
PharMerica Co. (NYSE:PMC) opened at $29.25 on Friday. PharMerica Co. has a 52 week low of $22.00 and a 52 week high of $29.50. The company has a quick ratio of 1.79, a current ratio of 2.58 and a debt-to-equity ratio of 0.79. The firm has a market capitalization of $910.27, a P/E ratio of 47.95, a price-to-earnings-growth ratio of 1.27 and a beta of 0.82.
PharMerica (NYSE:PMC) last posted its quarterly earnings results on Thursday, November 9th. The company reported $0.46 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.49 by ($0.03). The business had revenue of $595.10 million during the quarter, compared to the consensus estimate of $596.80 million. PharMerica had a return on equity of 2.30% and a net margin of 0.54%. equities analysts anticipate that PharMerica Co. will post 1.92 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This article was originally posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.chaffeybreeze.com/2018/01/05/new-york-state-common-retirement-fund-sells-17854-shares-of-pharmerica-co-pmc.html.
PharMerica Company Profile
Want to see what other hedge funds are holding PMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PharMerica Co. (NYSE:PMC).
Receive News & Ratings for PharMerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharMerica and related companies with MarketBeat.com's FREE daily email newsletter.